Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
296
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$5.14B
-
Value change
-
+$128M
-
Put/Call ratio
-
0.98
-
Number of buys
-
136
-
Number of sells
-
-118
-
Price
-
$47.83
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2016
361 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2016.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 296 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 159M outstanding shares and own 67.77% of the company stock.
Largest 10 shareholders include FMR LLC (18.2M shares), Clearbridge Investments, LLC (12.1M shares), VANGUARD GROUP INC (9.05M shares), BAILLIE GIFFORD & CO (8.42M shares), BB BIOTECH AG (6.91M shares), WELLINGTON MANAGEMENT GROUP LLP (6M shares), WADDELL & REED FINANCIAL INC (5.74M shares), BlackRock Institutional Trust Company, N.A. (3.14M shares), BlackRock Fund Advisors (3.06M shares), and STATE STREET CORP (2.77M shares).
This table shows the top 296 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.